Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

hematopoietic and lymphoid cell neoplasm - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

hematopoietic and lymphoid cell neoplasm

MONDO:0044881

Also known as:HEMOLYMPHORETICULAR tumor, malignanthaematological neoplasmhaematological tumour

Find Clinical TrialsTrials

Overview

A neoplasm arising from hematopoietic cells found in the bone marrow, peripheral blood, lymph nodes and spleen (organs of the hematopoietic system). Hematopoietic cell neoplasms can also involve other anatomic sites (e.g. central nervous system, gastrointestinal tract), either by metastasis, direct tumor infiltration, or neoplastic transformation of extranodal lymphoid tissues. The commonest forms are the various types of leukemia, Hodgkin and non-Hodgkin lymphomas, myeloproliferative neoplasms, and myelodysplastic syndromes.

Clinical Trials135 registered · 39 recruiting

Diagnosis

Biomarker and diagnostic research for hematopoietic and lymphoid cell neoplasm has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

135 clinical trials registered, 39 recruiting. Interventions under study include other interventions, drug therapy, procedural interventions, and biologic therapy. Pipeline includes 3 PHASE4, 5 PHASE3, 32 PHASE2. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT02586389](https://clinicaltrials.gov/study/NCT02586389)

Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:11 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 135 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Research summaries	150	48%
Disease patterns and progression	46	15%
Laboratory research	27	9%
New treatment approaches	26	8%
Testing and diagnosis research	22	7%
Clinical study results	16	5%
Other research	15	5%
Patient case studies	11	4%

hematopoietic and lymphoid cell neoplasm

Overview

Diagnosis

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications